Mesenchymal stem cells decrease lung inflammation during sepsis, acting through inhibition of the MAPK pathway

BACKGROUND: Sepsis is a severe medical condition that ranks among the top 10 causes of death worldwide and which has permanently high incidence rates. Mesenchymal stem cells (MSCs) have been found to be potent modulators of immune responses. More importantly, there is evidence that MSCs have a benef...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedrazza, Leonardo, Cubillos-Rojas, Monica, de Mesquita, Fernanda Cristina, Luft, Carolina, Cunha, Aline Andrea, Rosa, Jose Luis, de Oliveira, Jarbas Rodrigues
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741936/
https://www.ncbi.nlm.nih.gov/pubmed/29273091
http://dx.doi.org/10.1186/s13287-017-0734-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741936/
https://www.ncbi.nlm.nih.gov/pubmed/29273091
http://dx.doi.org/10.1186/s13287-017-0734-8

Ejemplares similares